Investigation of antimycotic susceptibility of Candida krusei clinical isolates from pulmonary tuberculosis patients

Kul'ko, A.B.

Antibiotiki i Khimioterapiia 53(11-12): 22-24

2008


ISSN/ISBN: 0235-2990
PMID: 19441653
Document Number: 13231
The results of the laboratory diagnosis of secondary infections of the bronchi and lungs due to Candida krusei strains isolated from patients with respiratory tract tuberculosis are presented. The activity of fluconazole, amphothericin B, itraconazole, ketoconazole, myconazole and 5-fluorocytosin against the C. krusei isolates from a tuberculosis clinic within 2003-2008 was tested. A decrease in the number of the C. krusei isolates susceptible to fluconazole from 30% in 2003 to 0% in 2008 was recorded.

Document emailed within 1 workday
Secure & encrypted payments

Investigation of antimycotic susceptibility of Candida krusei clinical isolates from pulmonary tuberculosis patients